Fior Markets launched a study titled “Arterial Stents Market by Type (Bare-Metal Stents, Drug-Eluting Stents, Bio absorbable Stents), Mode of Delivery, Material (Metallic Stents and Other Stents), End User, Region” and Global Forecast 2018-2025.
The global arterial stents market is expected to grow from USD 8.62 Billion in 2017 to USD 16.58 Billion by 2025 at a CAGR of 8.61% during the forecast period from 2018-2025. Increasing geriatric population which is prone to cardiovascular conditions and require latest treatments available in cardiac care are playing and advancements providing additional capabilities to enhance the workflow are driving the growth of the market.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/362196/request-sample
BVS based segment was valued around USD 3.39 Billion in 2017
Type segment includes BMS, BVS and drug eluting. BVS based segment was valued around USD 3.39 Billion in 2017. New product approvals aimed for young patient population are the major contributing factors to drive the demand of the segment in future.
Polymer segment held the largest market share of 59.31% in 2017
Material segment includes metal, polymer and copolymer. Polymer segment held the largest market share of 59.31% in 2017. Due to cost effectiveness and its minimal invasiveness nature makes it a preferred choice during the procedure.
Hospital segment is expected to grow with the highest CAGR of 10.68% in the forecast period
The end user segment includes hospital, cardiology center and ASC. The hospital segment is expected to witness the highest CAGR of 10.68% in the forecast period. There is a rise in awareness regarding peripheral artery diseases and cardiovascular disease. Introduction of innovative stents and rising healthcare expenditure in developed and developing economies are some of the key factors contributing for the growth of the market
Regional Segmentation Analysis:
The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. North America held the largest market share of approximately 54.31% in 2017. North America is a major manufacturing hub owing to the presence of large number of companies. North America region is dominating owing to favourable reimbursement policies and government support, which increases the product availability in the region. In addition to this, high prevalence of diseases and development of innovative bio-engineered absorbable products are some of the factors that led to the growth of market in this region.
The major players of market include Abbott Laboratories, Medtronic, plc, Boston Scientific Corporation, B. Braun Melsungen AG, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation (China), C. R. Bard, Inc., Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH, and others.
Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (firstname.lastname@example.org), who will ensure that you get a report that suits your needs.